Truist Securities Maintains Hold on National Health Investors, Raises Price Target to $58
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Michael Lewis has maintained a Hold rating on National Health Investors (NHI) and increased the price target from $55 to $58.
April 04, 2024 | 5:56 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities has maintained a Hold rating on National Health Investors and raised the price target from $55 to $58.
The increase in the price target by Truist Securities suggests a positive outlook on the stock's future performance, potentially leading to a short-term increase in its stock price. However, the Hold rating indicates that the analyst believes the stock might not outperform the market significantly in the near term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 90